FTC Takes Action Against Pharmacies Inflating Insulin Prices
The Federal Trade Commission (FTC) has launched a major investigation against three of the nation’s largest pharmacy benefit managers (PBMs) for allegedly inflating insulin prices, leaving patients across the U.S.…